[Management of diabetic nephropathy with nephrotic syndrome]

Nihon Rinsho. 2002 Oct:60 Suppl 10:430-6.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Diabetic Nephropathies / physiopathology
  • Diabetic Nephropathies / therapy*
  • Diet, Protein-Restricted
  • Diet, Sodium-Restricted
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypoglycemic Agents / therapeutic use
  • Nephrotic Syndrome / physiopathology
  • Nephrotic Syndrome / therapy*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Ultrafiltration

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents
  • Platelet Aggregation Inhibitors